EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EBOS Group Ltd (EBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11469
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and medical device suppliers. The company offers products under various brands such as Symbion, Pro Pharma, Minfosa, Master Pet, Vita Pet, Black Hawk and Faulding among others. EBOS serves private and public hospitals, general practitioners, aged care facilities, community centers, pharmacies, professionals, consumers, pet stores, veterinary clinics and manufacturers. It has operational presence in Australia and New Zealand. EBOS is headquartered in Docklands, Victoria, Australia.

EBOS Group Ltd (EBO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBOS Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBOS Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
EBOS Completes Private Placement Of Shares For US$73 Million 11
EBOS Announces Rights Issue Of Shares For US$121 Million 12
Acquisition 13
Ebos Group Receives Shareholders’ Approval To Acquire Symbion From Zuellig Group For US$886 Million 13
EBOS Group Ltd – Key Competitors 15
EBOS Group Ltd – Key Employees 16
EBOS Group Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Financial Announcements 19
Aug 23, 2018: EBOS delivers record 2018 earnings 19
Feb 21, 2018: EBOS delivers record first-half earnings 20
Aug 24, 2017: EBOS reports record earnings for 2017 22
Feb 22, 2017: EBOS Group Announces Strong first half delivers double-digit revenue and profit growth 24
Corporate Communications 26
Dec 13, 2017: EBOS Group announces its next CEO 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
EBOS Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBOS Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBOS Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
EBOS Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EBOS Completes Private Placement Of Shares For US$73 Million 11
EBOS Announces Rights Issue Of Shares For US$121 Million 12
Ebos Group Receives Shareholders' Approval To Acquire Symbion From Zuellig Group For US$886 Million 13
EBOS Group Ltd, Key Competitors 15
EBOS Group Ltd, Key Employees 16
EBOS Group Ltd, Other Locations 17
EBOS Group Ltd, Subsidiaries 17

List of Figures
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBOS Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBOS Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析
    Summary MYnd Analytics Inc (MYnd), formerly CNS Response Inc is a biotechnology company that offers medication development programs. The company performs analysis and research, and develops medication for individual patients suffering from mental health and other issues. It provides an PEER Online, …
  • AISIN SEIKI Co., Ltd.:企業の戦略・SWOT・財務情報
    AISIN SEIKI Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AISIN SEIKI Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • Fortress Biotech Inc (FBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others …
  • Merck & Co Inc (MRK)-製薬・医療分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mercuria Energy Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mercuria Energy Group Ltd (Mercuria Energy) is an independent energy and commodity company that carries out sourcing, supplying and trading of crude oil and refined petroleum products through its subsidiaries. Its portfolio includes petrochemicals, biofuels, environmental products, natural g …
  • Terna SpA (TRN)-エネルギー分野:企業M&A・提携分析
    Summary Terna S.p.A. (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers spec …
  • Highmark Inc:企業の戦略的SWOT分析
    Highmark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Buck Institute for Research on Aging:製薬・医療:M&Aディール及び事業提携情報
    Summary Buck Institute for Research on Aging (Buck Institute) is a biomedical institute that conducts research on aging and chronic disease. The institute concentrates on understanding the connection between aging and chronic disease. It carries out research and develops treatments in the therapeuti …
  • HAI Argochem (HAI):企業の財務・戦略的SWOT分析
    HAI Argochem (HAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Britannia Industries Limited:企業の戦略・SWOT・財務情報
    Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Britannia Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CHC Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary CHC Group Ltd (CHC) is a provider of helicopter services. The company offers various services including offshore transportation; search and rescue in challenging and hostile environments, from remote, perilous, and extreme terrains to offshore rescues; maintenance, repair, and overhaul; and …
  • Arkady Novikov Restaurant Group:企業の戦略・SWOT・財務分析
    Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report Summary Arkady Novikov Restaurant Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Goteborg Energi AB:企業の発電所・SWOT分析2018
    Goteborg Energi AB - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Infinity Turbine LLC:企業の戦略的SWOT分析
    Infinity Turbine LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Muscatine Power and Water:発電所・企業SWOT分析
    Muscatine Power and Water - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆